• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴有严重睑缘炎和眼表疾病的眼肌型重症肌无力:一例报告

Ocular Myasthenia Gravis with Severe Blepharitis and Ocular Surface Disease: A Case Report.

作者信息

Arnon Roee, Yahalomi Tal, Rozen-Knisbacher Irit, Pikkel Joseph, Mostovoy Dina

机构信息

Department of Ophthalmology, Assuta-Samson Medical Center, Ashdod, Israel.

Ben Gurion University School of Medicine, Beer-Sheva, Israel.

出版信息

Case Rep Ophthalmol. 2020 Jul 13;11(2):322-329. doi: 10.1159/000508815. eCollection 2020 May-Aug.

DOI:10.1159/000508815
PMID:32884545
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7443649/
Abstract

Ocular myasthenia gravis (OMG) is an autoimmune disease of the neuromuscular junction and commonly associated with other immune diseases. We describe a 16-year-old female who presented to our clinic with 1-month complaints of diplopia and strabismus, visual acuity deterioration, and ocular irritation. Her examination showed crossed diplopia and alternating exotropia of 25 prism diopters, severe blepharitis, conjunctival hyperemia, corneal pannus, epithelial irregularities, and subepithelial opacities. Workup included pediatric neurologic examination, laboratory tests, imaging, and electrophysiological tests. Diagnoses of OMG and blepharitis with ocular surface disease were made. Topical treatment included eyelid hygiene, tea tree oil scrubbing, topical steroids, and tacrolimus ointment. Systemic treatment included corticosteroids, pyridostigmine, azathioprine, intravenous immunoglobulins, amitriptyline, and doxycycline. Both diseases were refractory to intensive immunosuppressive treatment and had simultaneous relapses and an intertwined course. Our hypothesis is that a shared immune mechanism may be the cause of both OMG and ocular surface disease in our patient.

摘要

眼肌型重症肌无力(OMG)是一种神经肌肉接头处的自身免疫性疾病,通常与其他免疫性疾病相关。我们描述了一名16岁女性,她因1个月来的复视、斜视、视力下降和眼部刺激症状前来我们诊所就诊。她的检查显示交叉复视和25棱镜度的交替外斜视、严重睑缘炎、结膜充血、角膜血管翳、上皮不规则和上皮下混浊。检查包括儿科神经系统检查、实验室检查、影像学检查和电生理检查。诊断为OMG合并睑缘炎伴眼表疾病。局部治疗包括眼睑清洁、茶树油擦洗、局部类固醇和他克莫司软膏。全身治疗包括皮质类固醇、吡啶斯的明、硫唑嘌呤、静脉注射免疫球蛋白、阿米替林和多西环素。这两种疾病对强化免疫抑制治疗均耐药,同时复发且病程相互交织。我们的假设是,共同的免疫机制可能是我们患者OMG和眼表疾病的病因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70fc/7443649/ba2f08085b26/cop-0011-0322-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70fc/7443649/87e552d49550/cop-0011-0322-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70fc/7443649/f2a7fc1af7f2/cop-0011-0322-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70fc/7443649/ba2f08085b26/cop-0011-0322-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70fc/7443649/87e552d49550/cop-0011-0322-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70fc/7443649/f2a7fc1af7f2/cop-0011-0322-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/70fc/7443649/ba2f08085b26/cop-0011-0322-g03.jpg

相似文献

1
Ocular Myasthenia Gravis with Severe Blepharitis and Ocular Surface Disease: A Case Report.伴有严重睑缘炎和眼表疾病的眼肌型重症肌无力:一例报告
Case Rep Ophthalmol. 2020 Jul 13;11(2):322-329. doi: 10.1159/000508815. eCollection 2020 May-Aug.
2
Ocular myasthenia gravis in an academic neuro-ophthalmology clinic: clinical features and therapeutic response.学术性神经眼科诊所中的眼肌型重症肌无力:临床特征与治疗反应
J Clin Neuromuscul Dis. 2011 Sep;13(1):46-52. doi: 10.1097/CND.0b013e31821c5634.
3
Pediatric Ocular Myasthenia Gravis.小儿眼型重症肌无力
Curr Treat Options Neurol. 2019 Sep 26;21(10):46. doi: 10.1007/s11940-019-0593-y.
4
Case Report: Ocular Myasthenia Gravis Associated with In Vitro Fertilization Procedures.病例报告:体外受精程序相关的眼肌型重症肌无力
Optom Vis Sci. 2018 May;95(5):475-478. doi: 10.1097/OPX.0000000000001217.
5
Eye muscle antibodies in patients with ocular myasthenia gravis: possible mechanism for eye muscle inflammation in acetylcholine-receptor antibody-negative patients.眼肌型重症肌无力患者的眼肌抗体:乙酰胆碱受体抗体阴性患者眼肌炎症的可能机制。
Clin Immunol Immunopathol. 1998 Jun;87(3):276-81. doi: 10.1006/clin.1998.4536.
6
Long-term outcomes of pediatric ocular myasthenia gravis.儿童重症肌无力的长期预后
Ophthalmology. 2008 Jul;115(7):1245-1248.e1. doi: 10.1016/j.ophtha.2007.10.022. Epub 2007 Dec 26.
7
Ocular motor dysfunction and ptosis in ocular myasthenia gravis: effects of treatment.眼肌型重症肌无力的眼球运动功能障碍和上睑下垂:治疗效果
Br J Ophthalmol. 2005 Oct;89(10):1330-4. doi: 10.1136/bjo.2004.063404.
8
Ocular Myasthenia Gravis.眼肌型重症肌无力
Curr Treat Options Neurol. 2005 Jan;7(1):79-88. doi: 10.1007/s11940-005-0009-z.
9
Sero-Positive Isolated Ocular Myasthenia Gravis.血清阳性孤立性眼肌型重症肌无力
Cureus. 2024 Aug 14;16(8):e66885. doi: 10.7759/cureus.66885. eCollection 2024 Aug.
10
Immunosuppressive treatment of ocular myasthenia gravis.重症肌无力性眼病的免疫抑制治疗
BioDrugs. 2001;15(6):369-78. doi: 10.2165/00063030-200115060-00003.

引用本文的文献

1
Juvenile Ocular Myasthenia Gravis in a 3-Year-Old African Girl: A Case Report.一名3岁非洲女孩的青少年眼肌型重症肌无力:病例报告
Case Rep Ophthalmol. 2025 May 23;16(1):454-460. doi: 10.1159/000546374. eCollection 2025 Jan-Dec.
2
Epidemiology of Ocular Manifestations in Autoimmune Disease.自身免疫性疾病眼部表现的流行病学。
Front Immunol. 2021 Nov 2;12:744396. doi: 10.3389/fimmu.2021.744396. eCollection 2021.

本文引用的文献

1
Diagnosis and management of blepharitis: an optometrist's perspective.睑缘炎的诊断与管理:验光师的视角
Clin Optom (Auckl). 2016 Aug 8;8:71-78. doi: 10.2147/OPTO.S84795. eCollection 2016.
2
blepharitis: clinical perspectives.睑缘炎:临床视角
Clin Optom (Auckl). 2018 Jul 4;10:57-63. doi: 10.2147/OPTO.S142708. eCollection 2018.
3
Treatment of Myasthenia Gravis.重症肌无力的治疗
Neurol Clin. 2018 May;36(2):311-337. doi: 10.1016/j.ncl.2018.01.011.
4
Ocular surface alterations and in vivo confocal microscopic characteristics of corneas in patients with myasthenia gravis.重症肌无力患者的眼表改变及角膜的体内共聚焦显微镜特征
Eur J Ophthalmol. 2018 Sep;28(5):541-546. doi: 10.1177/1120672117753688. Epub 2018 Mar 19.
5
Tacrolimus Ointment for Refractory Posterior Blepharitis.他克莫司软膏治疗难治性睑缘炎
Curr Eye Res. 2017 Nov;42(11):1440-1444. doi: 10.1080/02713683.2017.1339805. Epub 2017 Sep 18.
6
Non-surgical interventions for acute internal hordeolum.急性睑腺炎的非手术干预措施。
Cochrane Database Syst Rev. 2017 Jan 9;1(1):CD007742. doi: 10.1002/14651858.CD007742.pub4.
7
Myasthenia Gravis.重症肌无力
N Engl J Med. 2016 Dec 29;375(26):2570-2581. doi: 10.1056/NEJMra1602678.
8
Update on Ocular Myasthenia Gravis.重症肌无力眼部病变的最新进展
Neurol Clin. 2017 Feb;35(1):115-123. doi: 10.1016/j.ncl.2016.08.008.
9
Efficacy of prednisone for the treatment of ocular myasthenia (EPITOME): A randomized, controlled trial.泼尼松治疗眼肌型重症肌无力的疗效(EPITOME):一项随机对照试验。
Muscle Nerve. 2016 Mar;53(3):363-9. doi: 10.1002/mus.24769. Epub 2016 Jan 27.
10
Current and Emerging Therapeutic Strategies for the Treatment of Meibomian Gland Dysfunction (MGD).当前和新兴的治疗方法用于治疗睑板腺功能障碍(MGD)。
Drugs. 2015 Jul;75(11):1177-85. doi: 10.1007/s40265-015-0432-8.